Provivi announces supply agreement for the bioproduction of pheromones

0

Successful scale-up with supplier EW Biotech enables Provivi to manufacture pheromones up to 20 metric tons per year

We are very satisfied with the partnership with EW Biotech. Both parties are also invested in growing this business and bringing the benefits of pheromones to farmers around the world. “

– Sanaz Imani, Director of Supply Chain and Purchasing operations

SANTA MONICA, CALIFORNIA, UNITED STATES, November 1, 2021 /EINPresswire.com/ – Provivi,® Inc., an emerging crop protection company using pheromones to protect crops from major pests, is pleased to announce the signing of a multi-year supply agreement with EW Biotech GmbH. EW Biotech is a bioprocess development, scale and contract manufacturing company based in Leuna, Germany. The agreement provides key raw materials for the Provivi FAW ™ (fall armyworm) and Pherium ™ (rice stem moth) product portfolio.

In 2020, Provivi stepped up its pheromone biosynthesis process in collaboration with EW Biotech to produce an essential component of Provivi FAW ™ and Pherium ™ pheromones. Commercial production has the capacity to protect the equivalent of 1.5 million hectares of corn against the deleterious effects of the fall armyworm, thus strengthening the manufacturing capacities of Provivi and EW Biotech.

“We are very pleased with the partnership with EW Biotech and their parent company EW Nutrition,” said Sanaz Imani, Director of Supply Chain and Supply Operations. “Both parties are also invested in growing this business and bringing the benefits of pheromones to farmers around the world.”

“This agreement is an important next step in ensuring the delivery of affordable and effective pheromone-based crop protection products through the use of synthetic biology and fermentation,” said Mike Chen, associate vice president of development of bioprocesses. “We look forward to working with EW Biotech to bring innovative pheromone products to market that support sustainable agriculture.”

“We are proud to see the close partnership between Provivi and EW Biotech translating into significant progress towards the widespread implementation of sustainable crop protection,” said Tonchy Ugrinovic, Chief Commercial Officer, EW Biotech.

From its inception, Provivi has been committed to sustainability by instituting a foundation that uses both greener chemistry based on metathesis and synthetic biology, giving growers access to greener pest control tools. This multi-year agreement will allow Provivi to supply the Provivi FAW ™ product to growers with up to 4.5 million hectares of cover over three years.

About Provivi
Provivi is a groundbreaking scientific company creating scalable and safer insect control technology that will improve the quality of life for all humans and our world.

Provivi is developing a family of safe, effective and economical pheromone-based mating disruption products, providing alternative technology as a new basis for pest and resistance management in agricultural production. Provivi’s patented production method allows for a radical change in the cost of manufacturing pheromones, allowing the use of this proven tool in large area crops such as corn, rice and soybeans.

For more information on Provivi, please visit www.provivi.com.

About EW Biotech
EW Biotech is a leading service provider in process development, scaling and custom manufacturing of biotech processes and products.

Based in Leuna, Germany, EW Biotech provides complete solutions, from lab scale to demonstration scale, from 1L to 85,000L. Combined with the know-how of the German team, the capabilities of EW Biotech place it in a unique position to serve customers around the world.

For more information, please visit www.ew-biotech.com.

Media contact
Ani Mikaelian, Global Communication Manager: [email protected]
Isabel Waengler, isabel global sales manager: [email protected]

Ani Mikaelian
Provivi, Inc
write us here
Visit us on social networks:
Facebook
Twitter
LinkedIn



Source link

Leave A Reply

Your email address will not be published.